Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 256 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

NCT07049926

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • UCSF Medical Center at Mission Bay ( Site 5008) San Francisco, California, United States
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5026) Mineola, New York, United States
  • Laura and Isaac Perlmutter Cancer Center ( Site 5016) New York, United States
  • Memorial Sloan Kettering Cancer Center ( Site 5002) New York, United States
View all 32 locations
View Trial Details
Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • The University of Nebraska Medical Center Omaha, Nebraska, United States
View all 22 locations
View Trial Details
Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +82 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of California, San Diego La Jolla, California, United States
View all 57 locations
View Trial Details
Recruiting

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

NCT07594106

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • City of Hope Phoenix Goodyear, Arizona, United States
  • City of Hope Duarte, California, United States
  • City of Hope Chicago, City of Hope Cancer Center Chicago Zion, Illinois, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

NCT06750185

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +28 more
Locations
  • Norton Cancer Institute PARENT Louisville, Kentucky, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Carolina BioOncology Institute, LLC Huntersville, North Carolina, United States
  • Rhode Island Hospital East Providence, Rhode Island, United States
View Trial Details
Recruiting

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

NCT05287945

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
Locations
  • Stanford Palo Alto, California, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
  • START Lisbon - Hospital de Santa Maria Av Lisbon, Portugal
View Trial Details

Related conditions